Assistant Professor, Medicine, University of Miami School of Medicine

Hematology

Doctor Juan C. Ramos, MD works in the field of Hematology. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Juan C. Ramos, MD is a published MD as well. He has 16 publications published. The latest was: Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma. Juan Ramos is registered with Medicare.

Publications

---

• Human T-Cell Leukemia Virus Type 1 (HTLV-1) Tax Requires CADM1/TSLC1 for Inactivation of the NF-κB Inhibitor A20 and Constitutive NF-κB Signaling.
• Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related Lymphoma: AIDS Malignancy Consortium Study 047.
• Newly Emerging Therapies Targeting Viral-Related Lymphomas.
• Oncogenic IRFs Provide a Survival Advantage for EBV- or HTLV1- Transformed Cells through Induction of BIC Expression.
• Primary CNS Lymphoma in HIV positive and negative patients: comparison of clinical characteristics, outcome and prognostic factors.
• Efficacy of bortezomib in a direct xenograft model of primary effusion Lymphoma.
• Adult T-cell Leukemia/lymphoma development in HTLV-1-infected humanized SCID mice.
• Definition, prognostic factors, treatment, and response criteria of adult T-cell Leukemia-lymphoma: a proposal from an international consensus meeting.
• EBV microRNAs in primary Lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3.
• Deregulated expression of CD40 ligand in HTLV-I infection: distinct mechanisms of downregulation in HTLV-I-transformed Cell lines and ATL patients.
• IRF-4 and c-Rel expression in antiviral-resistant adult T-cell Leukemia/lymphoma.
• Azidothymidine inhibits NF-kappaB and induces Epstein-Barr virus gene expression in Burkitt Lymphoma.
• Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin Lymphoma.
• Expression profiles of adult T-cell Leukemia-lymphoma and associations with clinical responses to zidovudine and interferon alpha.
• Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell Leukemia virus-associated adult T-cell Leukemia lymphoma.

Schools

---

• UmdnjNew Jersey Medical School

• Jackson Mem HospJackson Health

Procedures Preformed

---

• Plasmapheresis
• Thoracentesis

Conditions Treated

---

• Acute Leukemia
• Anal and Rectal Cancer
• Anemia
• Antiphospholipid Syndrome (APS)
• View All

Doctors Specialties

---

• Hematology
• Medical Oncology
• Oncology

Accepted Insurances

---

Awards

---

• CMS Meaningful Use Stage 1 Certification

Education

---

• Jackson Memorial Hospital - Jackson Health System

Hospital

---

• University of Miami Hospital
• Miami Veterans Affairs Healthcare System

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Adriana M. Milillo-Naraine, MD This Doctor is OpenDoctor Recommended.
	Dr. Elizabeth T. Velasquez, MD
	Dr. Pasquale W. Benedetto, MD This Doctor is OpenDoctor Recommended.
	Dr. Steven G. Fein, MD This Doctor is OpenDoctor Recommended.
	Dr. Thomas J. Harrington, MD This Doctor is OpenDoctor Recommended.
	Dr. Lawrence Negret, MD This Doctor is OpenDoctor Recommended.
	Dr. Caio Max S. Rocha-Lima, MD This Doctor is OpenDoctor Recommended.
	Dr. Joseph D. Rosenblatt, MD
	Dr. Leonard A. Kalman, MD This Doctor is OpenDoctor Recommended.
	Dr. Charles L. Vogel, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Jonathan Cohen, MD This Doctor is OpenDoctor Recommended.
	Dr. Ikechukwu I. Akunyili, MD This Doctor is OpenDoctor Recommended.
	Dr. Norberto Cartagena, MD This Doctor is OpenDoctor Recommended.
	Dr. Peter J. Hosein, MD This Doctor is OpenDoctor Recommended.
	Dr. Jack D. Temple Jr., MD
	Dr. Frank I. Singleton Jr., MD This Doctor is OpenDoctor Recommended.
	Dr. Michele D. Astarita, MD
	Dr. Jennifer Cudris Maldonado, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog